Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

ABCTB Investigators, HEBON Investigators, BCFR Investigators, OCGN Investigators, GEMO Study Collaborators, EMBRACE Collaborators, GC-HBOC study Collaborators

Producción: Contribución a una revistaArtículorevisión exhaustiva

32 Citas (Scopus)

Resumen

Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER−). We further compared associations with ER+ and ER− subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER– breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER− breast cancer.

Idioma originalInglés
Páginas (desde-hasta)442-468
Número de páginas27
PublicaciónGenetic Epidemiology
Volumen44
N.º5
DOI
EstadoPublicada - 01 jul. 2020

Huella

Profundice en los temas de investigación de 'Transcriptome-wide association study of breast cancer risk by estrogen-receptor status'. En conjunto forman una huella única.

Citar esto